Thyroid medication recall upgraded to FDA's highest risk level
A thyroid medication that was recalled last month because it’s potentially “superpotent" has been upgraded to the Food and Drug Administration’s highest risk level.
Story not found
← Return to briefing
A thyroid medication that was recalled last month because it’s potentially “superpotent" has been upgraded to the Food and Drug Administration’s highest risk level.